Business
fromBoston.com
5 days agoEli Lilly snaps up Watertown biotech in $2.4 billion deal
Eli Lilly will acquire Orna Therapeutics for $2.4 billion to integrate Orna’s in‑body circular RNA cell therapy platform into Lilly’s genetic medicine pipeline.